
Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims
ABSTRACT Objectives: This study evaluated whether the combined use of continuous glucose monitoring (CGM) and semaglutide, a glucagon-like peptide-1 receptor agonist, was associated with larger hemoglobin A1c (HbA1c) improvements compared with use of …